Home / quality patient safety / ischemic heart disease
IJN is the regional and national referral centre for percutaneous coronary intervention (PCI). A total of 16,589 cardiac catheterization procedures were performed in 2022 to treat patients with simple and complex ischemic heart disease.
One of the key performance measures is the use of appropriate medications before and after PCI.
From the year 2020 to 2022, IJN achieved 98% use for all medication categories, which is comparable with ACC-National Cardiovascular Data Registry (NCDR).
**Source of data: Cardiology Quality Indicators database
The rate of in-hospital mortality among patients who had PCI procedures at IJN in 2022 is lower compared with ACC- National Cardiovascular Data Registry (NCDR).
IJN continues to improve door-to-balloon time to reduce the risk of mortality and morbidity, well below the target of 90 minutes for emergency treatment of Acute Myocardial Infarction or heart attacks. (American College of Cardiology/American Heart Association (ACC/AHA) guidelines for PCI inflation).
IJN median door-to-balloon time was 50 minutes in 2022.
In 2022, IJN performed more cardiac catheterization procedures using radial access than other comparable hospitals(n= 7550).
The use of radial access is associated with reduction in bleeding complications, readmission rates, infection, and recovery time compared with PCI procedures done using a femoral approach.
